Perfusion changes with photic stimulation during two phases of the menstrual cycle: A pilot study comparing controls and true menstrual migraine patients

Cephalalgia

Volumn 23, Issue 9, 2003, Pages 907-913

  Ances, B M ^a   Detre, J A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Oestrogen withdrawal; Perfusion imaging; True menstrual migraines

Indexed keywords

ATENOLOL; DESIPRAMINE; DOCUSATE SODIUM; NAPROXEN; NORTRIPTYLINE; PARACETAMOL; PROPANOL; SUMATRIPTAN; VERAPAMIL;

ADULT; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE; OCCIPITAL LOBE; PHOTOSTIMULATION; PILOT STUDY; VISUAL STIMULATION;

ADULT; CEREBROVASCULAR CIRCULATION; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MAGNETIC RESONANCE IMAGING; MIGRAINE DISORDERS; OCCIPITAL LOBE; PHOTIC STIMULATION; PREMENSTRUAL SYNDROME;

EID: 0242361661     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00625.x     Document Type: Article

References (35)

1. Epstein MT, Hockaday JM, Hockaday TD. Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975; 1:543-8.
2. Silberstein SD. Hormone-related headache. Med Clin North Am 2001; 85:1017-35.
3. Silberstein SD. Sex hormones and headache. Rev Neurol (Paris) 2000; 156:4S30-41.
4. Silberstein SD, Merriam GR. Menstrual migraine. Del Med J 1991; 63:477-84.
5. Silberstein SD, Merriam GR. Physiology of the menstrual cycle. Cephalalgia 2000; 20:148-54.
6. Waters WE, O'Connor PJ. Epidemiology of headache and migraine in women, J Neurol Neurosurg Psychiatry 1971; 34:148-53.
7. Marcus DA. Interrelationships of neurochemicals, estrogen, and recurring headache. Pain 1995; 62:129-39.
8. Silberstein SD. Migraine and women. The link between headache and hormones. Postgrad Med 1995; 97:147-53.
9. MacGregor EA. 'Menstrual' migraine: towards a definition. Cephalalgia 1996; 16:11-21.
10. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975; 25:239-44.
11. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22:355-65.
12. Cao Y, Welch KM, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999; 56:548-54.
13. Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001; 98:4687-92.
14. Dietrich T, Krings T, Neulen J, Willmes K, Erberich S, Thron A et al. Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. Neuroimage 2001; 13:425-32.
15. Veltman DJ, Friston KJ, Sanders G, Price CJ. Regionally specific sensitivity differences in fMRI and PET. where do they come from? Neuroimage 2000; 11:575-88.
16. Olesen J. The International Headache Society classification and diagnostic criteria are valid and extremely useful. Cephalalgia 1996; 16:293-6.
17. Olesen J Lipton RB. Migraine classification and diagnosis. International Headache Society criteria. Neurology 1994; 44:S6-10.
18. Olesen J, Rasmussen BK. The International Headache Society classification of chronic daily and near-daily headaches: a critique of the criticism, Cephalalgia 1996; 16:407-11.
19. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996; 16:1236-49.
20. Detre JA, Alsop DC. Perfusion magnetic resonance imaging with continuous arterial spin labeling. Methods and clinical applications in the central nervous system. Eur J Radiol 1999; 30:115-24.
21. Detre JA, Floyd TF. Functional MRI and its applications to the clinical neurosciences. Neuroscientist 2001; 7:64-79.
22. Talairach J, Tournoux P, Musolino A, Missir O. Stereotaxic exploration in frontal epilepsy. Adv Neurol 1992; 57:651-88.
23. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging, Neurology 1997; 48:58-15.
24. Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies, Neuroimage 2001; 14:789-801.
25. Rode C, Wagner M, Gunturkun O. Menstrual cycle affects functional cerebral asymmetries. Neuropsychologia 1995; 33:855-65.
26. Sanders G, Wenmoth D. Verbal and music dichotic listening tasks reveal variations in functional cerebral asymmetry across the menstrual cycle that are phase and task dependent. Neuropsychologia 1998; 36:869-74.
27. Silberstein SD. Headache and female hormones: what you need to know. Curr Opin Neurol 2001; 14:323-33.
28. Case AM, Reid RL. Effects of the menstrual cycle on medical disorders. Arch Intern Med 1998; 158:1405-12.
29. Case AM, Reid RL. Menstrual cycle effects on common medical conditions. Compr Ther 2001; 27:65-71.
30. Digre K, Damasio H. Menstrual migraine: differential diagnosis, evaluation and treatment. Clin Obstet Gynecol 1987; 30:417-30.
31. Hurn PD, Littleton-Kearney MT, Kirsch JR, Dharmarajan AM, Traystman RJ. Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol. J Cereb Blood Flow Metab 1995; 15:666-72.
32. Salas E, Lopez MG, Villarroya M, Sanchez-Garcia P, De Pascual R, Dixon WR et al. Endothelium-independent relaxation by 17-alpha-estradiol of pig coronary arteries. Eur J Pharmacol 1994; 258:47-55.
33. Nattero G, Allais G, De Lorenzo C, Benedetto C, Zonca M, Melzi E et al. Relevance of prostaglandins in true menstrual migraine. Headache 1989; 29:233-8.
34. Nattero G, Allais G, De Lorenzo C, Torre E, Ancona M, Benedetto C et al. Menstrual migraine, new biochemical and psychological aspects. Headache 1988; 28:103-7.
35. Somerville BW. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975; 25:245-50.